Childress Capital Advisors LLC Boosts Holdings in Colgate-Palmolive (NYSE:CL)

Childress Capital Advisors LLC increased its holdings in shares of Colgate-Palmolive (NYSE:CL) by 8.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,428 shares of the company’s stock after buying an additional 187 shares during the period. Childress Capital Advisors LLC’s holdings in Colgate-Palmolive were worth $221,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in the business. Union Bancaire Privee UBP SA acquired a new position in shares of Colgate-Palmolive during the fourth quarter worth about $32,000. Reston Wealth Management LLC purchased a new position in Colgate-Palmolive in the third quarter worth approximately $42,000. Synergy Asset Management LLC acquired a new position in Colgate-Palmolive during the 4th quarter worth approximately $49,000. Capital Performance Advisors LLP purchased a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at approximately $53,000. Finally, Prospera Private Wealth LLC acquired a new stake in shares of Colgate-Palmolive in the 3rd quarter valued at $64,000. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

CL has been the topic of several recent analyst reports. JPMorgan Chase & Co. dropped their target price on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating on the stock in a report on Monday. Morgan Stanley dropped their price objective on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a report on Monday. StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Barclays dropped their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. Finally, TD Cowen reduced their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $101.16.

Colgate-Palmolive Price Performance

Shares of CL opened at $86.56 on Wednesday. The company has a market capitalization of $70.72 billion, a price-to-earnings ratio of 24.59, a price-to-earnings-growth ratio of 3.61 and a beta of 0.44. Colgate-Palmolive has a fifty-two week low of $82.68 and a fifty-two week high of $109.30. The firm has a 50-day simple moving average of $91.19 and a 200-day simple moving average of $97.07. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.26 and a current ratio of 0.41.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same quarter in the previous year, the business posted $0.87 earnings per share. On average, equities research analysts anticipate that Colgate-Palmolive will post 3.74 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.31%. Colgate-Palmolive’s payout ratio is currently 56.82%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.